BioMarin Pharmaceutical
BMRN
#1328
Rank
NZ$23.95 B
Marketcap
$124.78
Share price
-0.64%
Change (1 day)
-13.45%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): NZ$0.90 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are NZ$2.85 Billion. , an increase over its 2023 earnings that were of NZ$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.94 B187.31%
2023 NZ$0.32 B26.07%
2022 NZ$0.26 B-298.51%
2021 -NZ$0.14 Billion78.04%
2020 -NZ$73.83 Million-55.36%
2019 -NZ$0.17 Billion-33.56%
2018 -NZ$0.25 Billion297.78%
2017 -NZ$62.59 Million-95.68%
2016 -NZ$1.45 Billion437.12%
2015 -NZ$0.27 Billion23.91%
2014 -NZ$0.22 Billion-29.25%
2013 -NZ$0.31 Billion49.23%
2012 -NZ$0.21 Billion171.11%
2011 -NZ$76.11 Million103.01%
2010 -NZ$37.49 Million-3903.54%
2009 NZ$0.98 M-98.31%
2008 NZ$58.3 M-189.7%
2007 -NZ$65 Million51.02%
2006 -NZ$43.05 Million-61.58%
2005 -NZ$0.12 Billion-56.59%
2004 -NZ$0.26 Billion95.13%
2003 -NZ$0.14 Billion12.09%
2002 -NZ$0.12 Billion73.19%
2001 -NZ$68.12 Million18.32%
2000 -NZ$57.57 Million19.65%
1999 -NZ$48.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.89 Billion-193.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.24 Billion-124.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.09 M-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.85 B 1,365.96%๐Ÿ‡ซ๐Ÿ‡ท France
-NZ$50.17 Million-105.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.37 B-60.08%๐Ÿ‡บ๐Ÿ‡ธ USA